Core H - The Protein Expression and Proteomics Core comprises two distinct, but highly interactive components at The Scripps Research Institute. Dr. John Elder, co-director, oversees the protein expression and purification component of the Core. Dr. Bruce Torbett, co-director, oversees the proteomics section, which provides state-of-the-art mass spectrometry, as well as other protein analytical methodology and instrumentation. The protein expression component facilitates the expression and purification of proteins required by the various CFAR-associated research programs. Moreover, the Core maintains in stock commonly used viral proteins, thus providing resources that may not otherwise be available to the community. The proteomic component of the Core provides state-of-the-art mass spectrometry instrumentation and bioinformatics, electrophoretic technologies, and additional bioanalytical instrumentation to analyze viral and cellular proteins important to ongoing studies by the members of the CFAR program. The Core also provides protein expression and proteomic advice, training, and consultation to the CFAR community. Access to such advice, reagents, methodologies, and technologies provides the CFAR community with unique resources not commonly found in research laboratories or cores.
The Protein Expression and Proteomics Core provides to CFAR-associated research programs services for the expression and purification of viral and cellular proteins as well as proteomic analyses of proteins from viruses and infected tissues and cells. The availability of advice, training, consultation, reagents, methodologies, and technologies offered by the Core is commonly beyond the reach of many research groups and, as such, is highly significant to the overall success ofthe CFAR research program.
|Heaton, Robert K; Franklin Jr, Donald R; Deutsch, Reena et al. (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60:473-80|
|Hepler, N Lance; Scheffler, Konrad; Weaver, Steven et al. (2014) IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform. PLoS Comput Biol 10:e1003842|
|Szumowski, Suzannah C; Botts, Michael R; Popovich, John J et al. (2014) The small GTPase RAB-11 directs polarized exocytosis of the intracellular pathogen N. parisii for fecal-oral transmission from C. elegans. Proc Natl Acad Sci U S A 111:8215-20|
|Murrell, Ben; Murrell, Daniel; Murrell, Hugh (2014) R2-equitability is satisfiable. Proc Natl Acad Sci U S A 111:E2160|
|Grant, Igor; Franklin Jr, Donald R; Deutsch, Reena et al. (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82:2055-62|
|Blattner, Claudia; Lee, Jeong Hyun; Sliepen, Kwinten et al. (2014) Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity 40:669-80|
|Cachay, Edward R (2014) The forgotten component in the staging and management of HIV/hepatitis C virus-coinfected patients. Clin Infect Dis 59:320-1|
|Jeong, Su Jin; Kim, Min Hyung; Song, Je Eun et al. (2014) Short communication: prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients. AIDS Res Hum Retroviruses 30:827-9|
|Wang, Cathy X; Sather, Blythe D; Wang, Xuefeng et al. (2014) Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells. Blood 124:913-23|
|Scheffler, Konrad; Murrell, Ben; Kosakovsky Pond, Sergei L (2014) On the validity of evolutionary models with site-specific parameters. PLoS One 9:e94534|
Showing the most recent 10 out of 522 publications